MML Investors Services LLC grew its position in ICON plc (NASDAQ:ICLR) by 18.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 7,216 shares of the medical research company’s stock after purchasing an additional 1,137 shares during the quarter. MML Investors Services LLC’s holdings in ICON were worth $809,000 at the end of the most recent reporting period.
A number of other large investors also recently made changes to their positions in ICLR. Aperio Group LLC lifted its stake in shares of ICON by 4.6% in the fourth quarter. Aperio Group LLC now owns 15,640 shares of the medical research company’s stock valued at $1,754,000 after purchasing an additional 682 shares during the period. GW&K Investment Management LLC raised its position in ICON by 6.5% during the fourth quarter. GW&K Investment Management LLC now owns 11,496 shares of the medical research company’s stock worth $1,289,000 after acquiring an additional 700 shares during the last quarter. Stifel Financial Corp raised its position in ICON by 2.1% during the third quarter. Stifel Financial Corp now owns 36,545 shares of the medical research company’s stock worth $4,160,000 after acquiring an additional 763 shares during the last quarter. Sentry Investment Management LLC raised its position in ICON by 2.1% during the fourth quarter. Sentry Investment Management LLC now owns 37,807 shares of the medical research company’s stock worth $4,240,000 after acquiring an additional 763 shares during the last quarter. Finally, FineMark National Bank & Trust raised its position in ICON by 35.1% during the fourth quarter. FineMark National Bank & Trust now owns 3,855 shares of the medical research company’s stock worth $432,000 after acquiring an additional 1,002 shares during the last quarter. Hedge funds and other institutional investors own 90.59% of the company’s stock.
ICLR has been the subject of a number of recent analyst reports. KeyCorp restated a “buy” rating and issued a $130.00 target price on shares of ICON in a report on Thursday, January 11th. BidaskClub downgraded shares of ICON from a “buy” rating to a “hold” rating in a research note on Friday. Mizuho reaffirmed a “neutral” rating and issued a $114.00 price target (up from $109.00) on shares of ICON in a report on Thursday, February 15th. Zacks Investment Research cut shares of ICON from a “buy” rating to a “hold” rating in a report on Wednesday, January 10th. Finally, ValuEngine upgraded shares of ICON from a “hold” rating to a “buy” rating in a research report on Tuesday, February 13th. Four research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the stock. ICON presently has an average rating of “Buy” and a consensus price target of $126.00.
ICLR traded down $0.77 during midday trading on Friday, hitting $111.38. 318,886 shares of the company’s stock traded hands, compared to its average volume of 326,560. The firm has a market cap of $6,088.44, a PE ratio of 20.66, a PEG ratio of 1.60 and a beta of 0.42. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.95 and a current ratio of 1.95. ICON plc has a one year low of $76.46 and a one year high of $124.65.
ICON (NASDAQ:ICLR) last announced its quarterly earnings results on Thursday, February 15th. The medical research company reported $1.43 EPS for the quarter, beating the consensus estimate of $1.41 by $0.02. The company had revenue of $455.10 million for the quarter, compared to the consensus estimate of $455.66 million. ICON had a return on equity of 27.55% and a net margin of 16.01%. The company’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same quarter last year, the company posted $1.33 earnings per share. sell-side analysts anticipate that ICON plc will post 6.02 earnings per share for the current fiscal year.
COPYRIGHT VIOLATION WARNING: This story was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this story on another site, it was illegally copied and reposted in violation of United States and international trademark & copyright legislation. The original version of this story can be accessed at https://www.dispatchtribunal.com/2018/04/07/mml-investors-services-llc-purchases-1137-shares-of-icon-plc-iclr.html.
ICON Public Limited Company, a clinical research organization, provides outsourced development services to the pharmaceutical, biotechnology, and medical device industries in Ireland, rest of Europe, the United States, and internationally. It specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.
Receive News & Ratings for ICON Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICON and related companies with MarketBeat.com's FREE daily email newsletter.